Medicine
Lipiodol 4800 mg/10 mL injection
Lipiodol 4800 mg/10 mL injection is a prescription medicine containing Ethiodized oil for intra-arterial, intralymphatic, intrauterine use, marketed by Guerbet, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 15°-30°C (59°-86°F). Protect from light.
Key facts
- Active ingredient (INN)
- Ethiodized oil
- Brand
- Lipiodol
- Strength
- 4800 mg/10 mL
- Dosage form
- Injection
- Route
- Intra-arterial, intralymphatic, intrauterine
- Packs
- 1 ampule of 10 mL, 1 vial of 10 mL
- Marketing authorisation holder
- Guerbet
- Manufacturer
- Guerbet
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 15°-30°C (59°-86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V08AD01 Ethiodized oil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 March 2014
- Identifiers
- DailyMed set ID 511d1f64-5cb9-4baa-a123-96205467e59aNDC 67684-1901Application NDA009190
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 March 1954 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Ethiodized oil is a radiographic contrast agent indicated for hysterosalpingography in adults lymphography in adult, among other approved uses. It is available as injection for intra-arterial, intralymphatic and intrauterine use. MedsAcross supplies Ethiodized oil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ethiodized oilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LIPIODOL prescribing information (Guerbet) · U.S. National Library of Medicine, DailyMed
Need Lipiodol 4800 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.